Lam Research (LRCX)

The molybdenum monopoly is the sleeper story - LRCX is the only company with production-ready ALD moly tools as AI performance demands force the industry away from tungsten, creating a 3x SAM expansion they'll dominate. Everyone will focus on the record foundry revenues, but the real signal is Doug pre-emptively guiding December margins down to 48% as the China surge reverses. The binding constraint isn't demand but customer project timing - management refuses to guide 2026 despite strong positioning because they can't control when customers flip the switch on multi-billion dollar fabs. As Tim said, 'We don't control the customer's project timing, but we feel incredibly confident that when those projects go, Lam expands our SAM and gain share.' My view changes if molybdenum adoption stalls or if the December margin compression exceeds guidance, signaling structural rather than mix-driven pressure.